Results 151 to 160 of about 1,351 (168)

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

Cell Host and Microbe, 2020
Maozhou He, Longfa Xu, Qingbing Zheng
exaly  

An outbreak of a novel recombinant Coxsackievirus A4 in a kindergarten, Shandong province, China, 2021

Emerging Microbes and Infections, 2022
Xiufan Liu, Mengyuan Cao, Weijia Xing
exaly  

Protective Role for Interferon-β in Coxsackievirus B3 Infection

Circulation, 2004
Eleanor N Fish
exaly  

Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis.

Journal of Experimental Medicine, 1985
K W Beisel, Noel R Rose, Beisel K W
exaly  

Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide

Expert Review of Anti-Infective Therapy, 2015
Lianlian Bian, Qunying Mao, Miao Xu
exaly  

Genotypic variation in Coxsackievirus B5 isolates from three different outbreaks in the United States

Virus Research, 1995
H Kopecka, M Pallansch
exaly  

Coxsackievirus B infections in adults.

Texas medicine, 1977
A W, McCracken, G J, Race
openaire   +1 more source

Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes

Autoimmunity Reviews, 2009
Martin J Richer, Marc S Horwitz
exaly  

The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3

Phytomedicine, 2009
Haibo Wang, Yuanyuan Ding, Siwang Wang   +2 more
exaly  

The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease

Vaccine, 2018
Hyun Ju In, Gyung Tae Chung, Young Ki Choi   +2 more
exaly